View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
May 20, 2021updated 11 Mar 2022 6:25am

Philips unveils new spectral computed tomography device

Philips unveils a new computed tomography system that offers spectral images for all patients to enable better diagnosis.

Royal Philips has unveiled its Spectral Computed Tomography 7500, an intelligent system that offers spectral images for all patients to enable accurate diagnosis.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

This spectral detector-based system provides quality images for every patient, on every scan, all the time, the company noted. The device even delivers images for cardiac, paediatric and bariatric patients.

It can enhance disease characterisation and lower the need for rescans and follow-ups at the same dose levels used by standard scans.

The spectral workflow, which is said to be time-saving, is completely integrated to allow the technologist to scan the patient rapidly.

Philips noted that the spectral chest scans and head scans require less than one second while a full upper body spectral scan takes less than two seconds.

The device can also provide high-quality images that permit the doctor to quickly offer a diagnosis and efficient treatment plan for individual patients.

Royal Philips precision diagnosis chief business leader Kees Wesdorp said: “This latest intelligent system helps to bring clarity to defining moments in healthcare by delivering on certainty, simplicity and reliability in every clinical area from cardiac care to emergency radiology, diagnostic oncology, intervention and radiation oncology.

“Our detector-based spectral technology ensures spectral data is always available and is seamlessly integrated into current workflows, meaning scans are fast, and clinicians are able to send patients the right treatment pathway with a more confident diagnosis.”

Spectral computed tomography has shown a greater sensitivity in identifying malignant findings and has enhanced readings of incidental findings, the company noted.

With the new system, spectral insights will be available for all patients and any clinical indication, such as cardiac scans with high and irregular heart rates. The device does not impact image quality, dose or workflow, Philips added.

Furthermore, the spectral workflow aids radiologists to enhance reading with spectral results and artificial intelligence-based tools available in various reading environments with Spectral Magic Glass on picture archiving and communication system.

Last month, the US Food and Drug Administration granted 510(k) clearance to Philips ’ SmartCT image acquisition, visualisation and measurement software.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network